World Leading Speakers
Kate Adcock, Director Of Research And Innovation, The Muscular Dystrophy U.K.
Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency
Tanya Aiden, Global Products Lead, BIOCAD
John Alter, Vice President Pricing And Market Access, Pfizer
Mauricio Alvarez Reyes, Independent, Independent
Sofie Alverlind, Project Manager, Swedish Association of Local Authorities and Regions
Ines Alves, President, ANDO Portugal
Einar Andreassen, Senior Adviser, Hta And Reimbursement, Norwegian Medicines Agency
Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI
Ramesh Arjunji, Senior Director Heor And Rwe, AveXis
Nadeem Ashraf, Medical Advisor - Diabetes, N/A
Kagan Atikeler, Pharmacist, Turkish Medicines and Medical Devices Agency
Dorthe Bartels, Strategic Adviser, Amgros
Alex Bastian, Vice President, Value & Market Access, Galapagos NV
Ulrike Beckert, Senior Patient Access Manager Dach, Sobi - Swedish Orphan Biovitrum AB (publ)
Antje Behring, Acting Head, Federal Joint Committee
Igor Beitia Ortiz De Zárate, Director Market Access Southern Europe Region, PTC Therapeutics
Tatyana Benisheva, Professor In Drug Regulatory Affairs, Bulgarian Association For Drug Information
Niri Bhimsan, Head - Health Technology Assessment, Discovery Health
Inge Bliestle, Chief Operating Officer, TolerogenixX
Nadia Bodkin, Rare Disease Advocacy Professional, Rare Advocacy Movement
Axel Boehnke, Director Market Access Eu North, PTC Therapeutics
Luc Boileau, Chairman And Chief Executive Officer, INESSS
Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh
Anna Bucsics, Project Advisor, MoCA - Mechanism of Coordinated Access to Orphan M
Rob Burley, Director Of Campaigns, Care And Support, The Muscular Dystrophy U.K.
Bradley Burnam, Chief Executive Officer, Turn Therapeutics
Nicki Catterick, Senior Director, Global Market Access And Pricing, Merck Group
David Catterick, Head Of Market Access Uk, AMGEN
Sandro Cesaro-Tadic, Head Pricing I8 & Product Pricing Strategies, Roche
Anjan Chatterjee, Global Head Of Real World Evidence, Boehringer Ingelheim Pharma GmbH & Co. KG
Deven Chauhan, Senior Director, Value Evidence Leader, GlaxoSmithKline
Americo Cicchetti, Director, Universita Cattolica Del Sacro Cuore
Ali Ciger, Commercial Director, Pain, Pfizer
Francesca Cook, Senior Director, Global Head Of Pricing And Market Access, RegenxBio
Warren Cowell, Market Access Director, Shionogi Inc
Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)
Omar Dabbous, Vice President, Health Economics And Outcomes Research, AveXis
Charles De Cidrac, Director Of Health Insurance, AXA
Rob De With, Head Of Rare Diseases Of Europe And Canada, Takeda
Carla Deakin, Programme Director - Commercial And Managed Access, NICE
Olga Diachenko, Market Access Manager Europe, Accord Healthcare
Vitaly Doban, Executive Director, Head Of Applied And Advanced Analytics (Rwe, Medical), Novartis
Valentin Dodonov, Deputy General Head Of Market Access, BIOCAD
Mark Duman, Nw Service Champion, Diabetes U.K.
Jenny Ebert, National Account Director, Genzyme Sanofi Corp
David Elvira, Heads Eu Public Affairs, Sanofi
Gottfried Endel, Ebm, Hta Team Leader, H.V.B.
Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband
Jaime Espin, Professor, Andalusian School Of Public Health
Gina Ewy, Head Of Global Market Access, Hansa Biopharma
Valerie Faillat, Head Of Sanofi Espoir Foundation, Sanofi
Diar Fattah, Global Director, Innovative Value Strategies and Evidence (Respiratory), AstraZeneca
Girisha Fernando, Independent, Independant
Martina Flammer, Senior Vice President, Head Of Corporate Customer Value, Boehringer-Ingelheim
Steven Flostrand, Senior Director Of Pricing And Market Access, Celgene
Douglas Foerster, Head Market Access Europe And Row, Santhera
Kamilla Gaitova, Head Of Center For Health Economics And Health Technology Assessment, Republican Center for Health Development, Kazakhstan
Jonathan Galduf, Market Access Manager, Sun Pharmaceutical Industries Limited
Benjamin Gannon, Vice President International Access, Policy and Advocacy, Myriad genetics
Oliver Gassner, Head G4A Digital Health Intelligence Emea, Bayer
Marcus Gaurdian, Chief Operating Officer, EUnetHTA
Katrien Van Geyt, Head Of Market Access, Belgium And Luxembourg, Takeda
Fabrizio Gianfrate, Professor Of Health Economics, Market Access Advisor, Universities of Rome and Ferrara
Ivan Glushkov, External Affairs Department Director, STADA CIS
Josie Godfrey, Director, JG Zebra Consulting
Wim Goettsch, Special Hta-Advisor, Zorginstituut
Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical
John P Hakanson, Global Head Of Strategic Pricing, CSL Behring
Stephen Hall, Knowledge Exchange Associate, NIHR Innovation Observatory, Newcastle University
Adam Heathfield, Senior Director Of Global Health And Value Innovation Centre, Pfizer Ltd
Ramon Hernandez Vecino, Head Of Real World Evidence Data and Analytics Engagement Lead RandD, Sanofi
Hans Hofstraat, Vice President, Philips Research
Stefan Holmstrom, Head, Hta Strategy And Pro Excellence, Astellas Pharma
Birgit Holz, Global Head Of Contracting Innovation, Sanofi
Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb
Nigel Hughes, Scientific Director, Rmeds Quantitative Sciences, Janssen
Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma
Carlo Incerti, Operating Partner, Forbion
Kankendria Ingram, Independent, Independent
Dawn Torrence Ireland, President And Founder, C.H.E.R.U.B.S.
Daniel Jackson, Global Head Of Market Access, Solutions And Strategy, UCB
Ulrike Jacobi, Head Of External Affairs And Market Access, AMGEN
David Jakouloff, Global Head Of Market Access, Dmd, PTC Therapeutics
Saira Jan, Director, Enterprise Pharmacy, Blue Cross Blue Shield of New Jersey
Rasmus Jensen, Global Head Of Market Access, Camurus
Elizabeth Johnson, Biologics Coordinator, Allergy Partners, P.A.
Wendy Jory, Head Of Global Pricing Centre Of Excellence, GlaxoSmithKline
Navin Joshi, Global Head Of Pricing, Classic And Established Products. Global Pharma, Head Of Pricing and Access Capabilities, Emerging Marke, GlaxoSmithKline
Marcela Junqueira, Head Of Strategic Affairs And Health Economics, Janssen Pharmaceutical
Madhusudan Kabra, Director, Evidence Generation, Otsuka Pharmaceutical
Gomathi Kaliappan, Global Market Access (Health Systems Strategy, Value Recognition), Roche
Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator Applications
Diane Kleinermans, Advisor To The Ministry Of Health And Social Affairs, Belgian Federal Government
Jolanda Koenders, Head Of Market Access Netherlands, Takeda
Shanthy Krishnaraja, Senior Director, Market Access And Strategy, Seqirus
Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG
Irina Kurashkina, Advisor, External Affairs Department, S.T.A.D.A.
Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems
Jost Leemhuis, Head Of Safety Science, Roche
Giovanny Leon, Pricing And Market Access Director For Latin America And Canada, Novartis AG
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Gavin Lewis, Intenational Access Lead, Amgen
Edmund Lim, Co-Founder, We CARE Journey
Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark
Julie Locklear, Head Of Global Health Economics and Outcomes Research, Argenx
Catarina Lopes Pereira, Market Access, Senior Manager and Coordinator Of The Value Added Medicines Sector Group, Medicines for Europe
Kevin Loth, Vice President, Corporate Affairs and Policy, Worldwide Markets, Celgene
Elena Lungu, Manager Of Policy Development, Government of Canada (Canada)
Mark Macgregor, Medical Director, Golden Jubilee National Hospital
Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Joerg Mahlich, Heor, Janssen Pharmaceutical K.K.
Andrea Mantovani, Former Head Of Value, Access And Policy For Biopharma Companies, Independent
Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita
Anne Marciniak, Head Of Market Access, Europe, Aimmune
Cristina Martin-Rinconada, Head Of Value And Access For International Partners Markets (Mena And Ceer Regions), Biogen
Kevin Mayo, Global Head Of Market Access And New Products, PTC Therapeutics
Vipul Modi, Head Of Transformation For Innovation, Digital And Life Sciences, Oxford Academic Health Science Network
Patrick Mollon, Heor Consultant, Gmap, Ipsen Pharma
Paolo Morgese, Director, Market Access And Member Relations, Alliance for Regenerative Medicine
Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany
Michael Müller, Head Of Market Access, Western Europe, SUN Pharma
Peter Mulley, Director Global Market Access, ViiV Healthcare
Diane Munch, VP, Global Pricing, Patient & Health Impact, Pfizer
Nuriya Musina, Head Of Development, Federal State Budgetary Institution, The Center For Healthcare Quality Assessme, Ministry of Health Russian Federation
Sue Naeyaert, Vice President Global Government Affairs, Policy And Pharmacoeconomics Biosimilars, Fresenius Kabi
Hanadi Nahas, Chairman And General Manager, Access Core
Inez Naidu, Head - Discovery Health Medicines Unit, Discovery Health
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Noluthando Nematswerani, Head - Centre For Clinical Excellence, Discovery Health
Claudia Neuber, Head Of Global Pricing Implementation, AstraZeneca
Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical
Adam Nosal, Head Of Market Access, Oncology Europe, AstraZeneca
Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh
Laura O'Hanlon, Director Of International Market Access, Policy and Advocacy, Myriad genetics
Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma
Amer Omar, Senior Director, Lupin
Vitaly Omelyanovskiy, General Director, Center Of Healthcare Quality Assessment And Control, Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R
Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC
Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre
Mario Ouwens, Senior Statistical Science Director, Astra Zeneca
Arrigo Paciello, Scientific Advisor, AIFA
Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, D.A.K.
Chris Pashos, Vice President Of Global Evidence Strategy, AbbVie
Julien Patris, Associate Director Of Market Access And Policy For Europe And Canada, Alnylam
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company
Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.
Diogo Piedade, Health Economics Advisor, Medicines for Europe
Sagie Pillay, Chief Operating Officer, Wits Health Consortium
Oresta Piniazhko, Director, Hta Department, Ministry of Health of Ukraine
Carme Pinyol, Head Of Pricing And Market Access Southern Europe, Pierre Fabre
Lara Pippo, Head Of Market Access, CSL Behring
Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics
Adam Plich, Managing Director, Plich Advisory
Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP
Angelina Irizari Policarpio, Head Of Heor And Real World Evidence Communications, Eisai
Caridad Pontes, Manager Of Pharmacotherapeutic Harmonization, Catalan Health Service
Robert Popovian, Vice President Of Government Relations, Pfizer
Diann Potestio, Vice President Market Access, Ascendis Pharma
Martin Price, Vice President Of Health Economics, Market Access And Reimbursement, Johnson & Johnson
Rajakanth Raman, Executive Director, Rainbow Across Borders Limited
Nuno Prego Ramos, Chief Executive Officer, CellmAbs
Kevin Rieger, Head Of Eu Affairs, BPI
Juan Roman, Head Of Market Access And Pricing, Acceleron Pharmaceuticals, Inc.
Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency
Micah Rose, Senior Scientific Adviser, Health Economic Modelling, National Institute for Health and Care Excellence
Igor Rudychev, Head Of Us Digital, Data, And Innovations, AstraZeneca
Peter Rutherford, Global Medical Lead Of Orphan Renal Diseases, Vifor Pharma Group
Ryan Saadi, Vice President, Global Market Access, CSL Behring
Marcelo Sal, Head Of Market Access And Pricing, Argentina, PTC Therapeutics
Yves Samel, Market Access Strategy Leader And Global Pricing Manager, Bayer
Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.
Gustavo Saraiva Dos Anjos, Global Market Access Director For Biologics, GlaxoSmithKline
Meriam Sbeity, Market Access Specialist, Access Core
Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda
Michael Schroter, Partner, Viopas Partners
Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN), the Netherlands
Nabil Seidov, Deputy Head Of Department For Health Policy And Planning Of Public Health And Reforms Centre, Ministry of Healthcare of Azerbaijan Republic
Ayman Semaan, Head Of Market Access, Algorithm
Simon Shohet, Senior Director, Global Market Access And Pricing, Ipsen
Rita Shorjian, Market Access Head - Near East And North West Africa, AbbVie
Dorinda Silva, Volunteer Patient Advocate, Portuguese Association for CDG and other Rare Metabolic Diseases
Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England
Matt Slabbert, Head Of Market Access, Advocacy And Policy, Anz, Bayer Pharmaceuticals
Stefan Sladecek, Head Of Market Access Austria, Roche Diagnostics
Sebastian Soluch, Head Of Market Access And Pricing, Europe, Stemline Therapeutics Inc
Ulf Staginnus, Senior Vice President, Head Of Global Market Access And Pricing, Ipsen Pharma
Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm
Richard Stephens, Patient Advocate, Independant
Giovanni Tafuri, Eunethta, Senior Scientific Officer, National Health Care Institute (ZIN), the Netherlands
Bertrand Tardivel, General Manager, Frehel GmbH
Samuel Taylor, Emerging Markets Pricing Lead, Pfizer
Renske Ten Ham, Researcher, Utrecht University
Bharat Tewarie, Executive Vice President And Chief Marketing Officer, UCB
David Thompson, Senior Vice President, Head Of Thought Leadership, Real World And Late Phase Research, Syneos Health
Gwilym Thompson, Director Worldwide Heor, BMS
Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD
Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany
Keiko Tone, Vice President Global Market Access, Shionogi Inc
Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health
Sheela Upadhyaya, Associate Director Hst, National Institute for Health and Care Excellence
Inneke Van De Vijver, Strategic Advisor – Reimbursement Pharmaceuticals, N.I.H.D.I.
Erik Van Den Berg, Chief Executive Officer, A.M. Pharma
Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences
Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health
Evert Jan Van Lente, Director Of Eu Affairs, AOK Bundesverdand
Christina Vandoros, Director, Macroeconomics And Health Policy - Emea, Janssen
Stefan Vegter, Market Access Manager, Novartis
Kart Veliste, Chief Specialist At Department Of Medicines And Medical Devices, Haigekassa Estonia
Marijn Verhoef, Engagement Manager, Access to Medicine Foundation
Bart Vermeulen, Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health, Belgian Federal Government
Jaume Vidal, Policy Advisor, Eu Projects, Health Action International
Reg Waldeck, Market Access Strategy Leader, Bayer Corp
David Watson, Director Pricing And Reimbursement, ABPI
Lindsay Weaver, Chief Executive Officer, Metabolic Support UK
Keith White, Vice President and Head, Global Market Access, Corbus Pharmaceuticals
Anne Willemsen, Project Manager EUnetHTA, Zorginstituut Nederland / EUnetHTA
Entela Xoxi, Former Aifa, Universita Cattolica Del Sacro Cuore
Natasa Zibelnik, Global Head Of Market Access, E.U.S.A. Pharma
Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals
Gergana Zlateva, VP, Payer Insights & Access, Global Health & Value, Pfizer
Fabrizio Zucca, Director Market Access Dach, Intercept Pharmaceuticals Inc
Contact us
To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052
edmond.rama@terrapinn.com
To speak:
Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com
Organiser
